Suppr超能文献

IB 期宫颈鳞状细胞癌根治性子宫切除术后的辅助放疗

Adjunctive radiation after radical hysterectomy in stage IB squamous cell carcinoma of the cervix.

作者信息

Remy J C, di Maio T, Fruchter R G, Sedlis A, Boyce J G, Sohn C K, Rotman M

机构信息

Department of Obstetrics and Gynecology, State University of New York-Health Science Center, Brooklyn 11203.

出版信息

Gynecol Oncol. 1990 Aug;38(2):161-5. doi: 10.1016/0090-8258(90)90033-h.

Abstract

The clinical-pathologic records of 178 women with stage IB squamous cell carcinoma treated by radical hysterectomy and pelvic node dissection were reviewed to assess prognostic factors and outcome in relation to adjunctive pelvic radiation. Among 32 women with pelvic nodes metastases, 19 treated with adjunctive radiation had longer recurrence-free intervals and more extrapelvic metastases than 13 nonirradiated women. However, among irradiated women recurrences were more rapidly fatal, so that the survival of the two groups was similar. Among 54 women with deeply invading (10 mm or more) carcinomas confined to the uterus, 17 with adjunctive radiation had recurrence-free intervals and survivals similar to 37 women without radiation, despite more high-risk factors in the irradiated group. The findings suggest that adjunctive pelvic radiation may control pelvic recurrence but not extend survival.

摘要

回顾了178例接受根治性子宫切除术和盆腔淋巴结清扫术治疗的IB期鳞状细胞癌女性患者的临床病理记录,以评估与辅助盆腔放疗相关的预后因素和结局。在32例有盆腔淋巴结转移的女性中,19例接受辅助放疗的患者与13例未接受放疗的患者相比,无复发生存期更长,但盆腔外转移更多。然而,在接受放疗的女性中,复发导致死亡的速度更快,因此两组的生存率相似。在54例局限于子宫的深度浸润性(10毫米或以上)癌女性中,17例接受辅助放疗的患者与37例未接受放疗的患者相比,无复发生存期和生存率相似,尽管放疗组有更多的高危因素。研究结果表明,辅助盆腔放疗可能控制盆腔复发,但不能延长生存期。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验